# The Role of IL5 in Epithelial Cell Integrity

> **NCT05895929** · EARLY_PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 8 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps
- Chronic Rhinosinusitis (Diagnosis)

## Interventions

- **DRUG:** Mepolizumab

## Key facts

- **NCT ID:** NCT05895929
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-05
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05895929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05895929, "The Role of IL5 in Epithelial Cell Integrity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05895929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*